Found 8 matching trials
Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis PHASE2 The purpose of this study is to assess feasibility, safety and preliminary ...
Show More Location
Rheumatology Clinic, St. Joseph's Health Care
Learn More & Join Trial
RituxiMab INDuction in Renal Transplantation PHASE4 Hypothesis:
* That B cell depletion, rather than reducing acute rejection,...
Show More Location
South West Transplant Centre
Learn More & Join Trial
Subcutaneous Abatacept in Renal Transplant Recipients PHASE1 After a kidney transplant, patients take drugs called anti-rejection drugs ...
Show More Learn More & Join Trial
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases NA This is a treatment guideline for an unrelated umbilical cord blood transpl...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies PHASE2 Blood and marrow stem cell transplant has improved the outcome for patients...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
HSCT for High Risk Inherited Inborn Errors PHASE2 Hematopoietic stem cell transplantation has proven effective therapy for in...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD PHASE2 To determine if rituximab administered after allogeneic transplantation dec...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies PHASE2 Recent advances in allogeneic hematopoietic cell transplantation (allo-SCT)...
Show More Location
Besançon University Hospital
Learn More & Join Trial